Search results
Dosing is Complete in Lexaria's Second GLP-1 Human Pilot Study
Digital Journal· 20 hours agoKELOWNA, BC / ACCESSWIRE / July 9, 2024 / Lexaria Bioscience Corp. (Nasdaq:LEXX & LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms announces that human pilot ...